PDGFB and mesenchymal cell neoplasm: The patient achieved a complete remission after 2 years and is still on Imatinib treatment.<h4>Conclusions</h4>COL1A1::PDGFB fusion-associated uterine fibrosarcoma is an extremely rare mesenchymal neoplasm.